Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Digestive Diseases and Sciences

• Publication date

  1988-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF01798351PMID 3282846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients.

  1988cited by this paper
• Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study.

  1987cited by this paper
• The irritable oesophagus--a frequent cause of angina-like pain.

  1987cited by this paper
• Inhibition of basal and betazole- and sham-feeding-induced acid secretion by omeprazole in man.

  1986cited by this paper
• The mechanism for inhibition of gastric (H+ + K+)-ATPase by omeprazole.

  1985cited by this paper
• Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

  1984cited by this paper
• Ranitidine in Reflux Oesophagitis

  1984cited by this paper
• Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease.

  1984cited by this paper
• Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study.

  1984cited by this paper
• Effect of daily oral omeprazole on 24 hour intragastric acidity.

  1983cited by this paper
• Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.

  1983cited by this paper
• Effect of daily oral omeprazole on 24 hour intragastric acidity.

  1983cited by this paper
• Controlled trial of cimetidine in reflux esophagitis

  1980cited by this paper
• Cimetidine in the treatment of severe ulcerative reflux oesophagitis; results of an 8-week double-blind study and of subsequent long-term maintenance treatment.

  1980cited by this paper
• [Treatment of reflux oesophagitis with cimetidine (author's transl)].

  1979cited by this paper
• Oral cimetidine in reflux esophagitis: a double blind controlled trial.

  1978cited by this paper
• A controlled trial of metoclopramide in symptomatic gastroesophageal reflux.

  1977cited by this paper
• Patterns of Gastroesophageal Reflux in Health and Disease

  1976cited by this paper
• Cholinergic therapy of chronic heartburn. A controlled trial.

  1974cited by this paper
• Role of acid and pepsin in acute experimental esophagitis.

  1969cited by this paper

• The Discrepancy Between Subjective and Objective Clinical Endpoints in Gastroesophageal Reflux Disease

  2022cites this paper
• Intrinsically Disordered Proteins: Critical Components of the Wetware.

  2022cites this paper
• Proton Pump Inhibitors in 2021: Pros, Cons, and Everything in Between

  2021cites this paper
• Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease

  2020cites this paper
• Diagnostic work up and indications for gastro-esophageal reflux surgery

  2020cites this paper
• HEART BURN IN PRIMARY CARE

  2019cites this paper
• Medical Management of GERD

  2019cites this paper
• ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats

  2018cites this paper
• Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders

  2018cites this paper
• The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Disorders.

  2018cites this paper
• Deprescribing versus continuation of chronic proton pump inhibitor use in adults.

  2017cites this paper
• Gastroesophageal reflux disease: A clinical overview for primary care physicians.

  2017cites this paper
• The Medical Management of Gastro-Oesophageal Reflux Disease

  2016cites this paper
• GERD: Diagnosing and treating the burn

  2015cites this paper
• Medical treatment versus surgery for treatment of gastroesophageal reflux disease

  2015cites this paper
• Recurrence and Its Impact on the Health-related Quality of Life in Patients with Gastroesophageal Reflux Disease: A Prospective Follow-up Analysis

  2015cites this paper
• Dyspepsia and Gastro-Oesophageal Reflux Disease: Investigation and Management of Dyspepsia, Symptoms Suggestive of Gastro-Oesophageal Reflux Disease, or Both

  2014influential citation
• Guía Práctica de la Asociación Centroamericana y del Caribe de Gastroenterología y Endoscopía Digestiva (ACCGED) para el manejo de la Enfermedad por Reflujo Gastroesofágico (ERGE)

  2014cites this paper
• Corrigendum: Diagnostic Testing in Extraesophageal GERD: Another Case of “Furor Medicus”?

  2013cites this paper
• Clinical Practice Guideline For the Diagnosis and Management of Gastroesophageal Reflux Disease

  2013cites this paper
• Corrigendum: Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease

  2013cites this paper
• WITHDRAWN: Medical treatments in the short term management of reflux oesophagitis.

  2011cites this paper
• Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis

  2010cites this paper
• Gastro-oesophageal reflux disease.

  2010cites this paper
• Esophagus Benign Diseases of the Esophagus

  2008cites this paper
• Disease-specific cost savings of treating nighttime versus daytime gastroesophageal reflux disease in an employed population

  2008cites this paper
• MEDICAL TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE

  2008cites this paper
• Medical treatments in the short term management of reflux oesophagitis.

  2007cites this paper
• Gastro-oesophageal reflux disease.

  2006cites this paper
• Prospective trial of laparoscopic Nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up

  2006cites this paper
• The EAES Clinical Practice Guidelines on Laparoscopic Antireflux Surgery for Gastroesophagel Reflux Disease (1997)

  2006cites this paper
• Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis.

  2005cites this paper
• Role of omeprazole in prevention and treatment of postendoscopic variceal sclerotherapy esophageal complications

  2005cites this paper
• Title Hepatic tight junctions : From viral entry to cancer metastasis

  2005cites this paper
• Gastroesophageal reflux.

  2005cites this paper
• Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: A

  2005cites this paper
• Efficacy of famotidine and omeprazole in healing symptoms of non‐erosive gastro‐oesophageal reflux disease: randomized‐controlled study of gastro‐oesophageal reflux disease

  2005cites this paper
• Macroscopic healing of esophagitis does not improve esophageal motility

  2005cites this paper
• Oesophageal and gastric pH profiles in patients with gastro‐oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors

  2004cites this paper
• Cost-minimization analysis of treatment of gastroesophageal reflux disease. Implications of varying holding time on conclusions.

  2004cites this paper
• A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials

  2004cites this paper
• WHAT IS THE BEST CURE FOR CHRONIC GERD? THE ONGOING DEBATE BETWEEN MEDICAL AND SURGICAL THERAPY

  2003cites this paper
• Noncardiac chest pain: evaluation and treatment.

  2003cites this paper
• Management of gastroesophageal reflux disease.

  2003cites this paper
• Cost-effectiveness and cost-utility of long-term management strategies for heartburn.

  2002cites this paper
• Medical or Surgical Therapy for Erosive Reflux Esophagitis: Cost–Utility Analysis Using a Markov Model

  2002cites this paper
• The Association of Gastroesophageal Reflux Disease with Asthma and Chronic Cough in the Adult

  2002cites this paper
• Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active‐controlled, double‐blind study

  2002cites this paper
• What Is the Optimal Medical Therapy for Barrett’s Esophagus?

  2001cites this paper
• Problems associated with the clinical use of proton pump inhibitors.

  2001cites this paper
• Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.

  2001cites this paper
• Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion

  2001cites this paper
• Long term omeprazole therapy for reflux esophagitis:follow-up in serum gastrin levels,EC cell hyperplasia and neoplasia.

  2000cites this paper
• Clinical experience with pantoprazole in gastroesophageal reflux disease.

  2000cites this paper
• Protective action of piperine against experimental gastric ulcer.

  2000cites this paper
• What is heartburn worth? A cost-utility analysis of management strategies.

  2000cites this paper
• A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease

  2000cites this paper
• What is heartburn worth?

  2000cites this paper
• Assessment of patient satisfaction with a formulary switch from omeprazole to lansoprazole in gastroesophageal reflux disease maintenance therapy.

  1999cites this paper
• Standard‐dose lansoprazole is more effective than high‐dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis

  1999cites this paper
• Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment

  1999cites this paper
• Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis

  1999cites this paper
• [Medical treatment of gastroesophageal reflux with proton pump inhibitors].

  1999cites this paper
• Overview of medical therapy for gastroesophageal reflux disease.

  1999cites this paper
• Gastroesophageal reflux and asthma: a review of pathogenesis, diagnosis, and therapy

  1999cites this paper
• pH, healing rate, and symptom relief in patients with GERD.

  1999cites this paper
• Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis

  1999cites this paper
• Respiratory complications of gastrointestinal diseases.

  1998cites this paper
• Determining the cost of gastroesophageal reflux disease: a decision analytic model.

  1998cites this paper
• Trends in the management of gastro-oesophageal reflux disease.

  1998cites this paper
• Meta- Analyses of Cisapride, Omeprazole and Ranitidine in the Treatment of GORD

  1998cites this paper
• Omeprazole in patients with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment.

  1998cites this paper
• Gastroesophageal reflux in infants and children.

  1998cites this paper
• Proton Pump Inhibitors

  1998cites this paper
• Medical therapy of gastroesophageal reflux and management of esophageal strictures.

  1997cites this paper
• Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta‐analysis of long‐term omeprazole trials

  1997cites this paper
• Fundic gland polyps developing during omeprazole therapy.

  1997cites this paper
• Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis.

  1997cites this paper
• Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis.

  1997cites this paper
• Laparoscopic antireflux surgery for gastroesophageal reflux disease (GERD)

  1997cites this paper
• Prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis of maintenance proton pump inhibition.

  1997cites this paper
• Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response.

  1997cites this paper
• Management in general practice of patients with persistent dyspepsia. A decision analysis.

  1997cites this paper
• Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands.

  1996cites this paper
• Proton pump inhibitory therapy: then and now.

  1996cites this paper
• Macroscopic versus microscopic diagnosis of reflux esophagitis: erosions or eosinophils?

  1996cites this paper
• Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.

  1996cites this paper
• Cost of acid peptic disorders in a managed-care organization.

  1996cites this paper
• Lansoprazole and omeprazole in the treatment of acid peptic disorders.

  1996cites this paper
• Predictive value of esophageal manometry and gastroesophageal pH monitoring for responsiveness of reflux disease to medical therapy in children.

  1996cites this paper
• The impact of omeprazole and laparoscopy upon hiatal hernia and reflux esophagitis.

  1996cites this paper
• Gastroesophageal reflux in childhood.

  1996cites this paper
• Clinical economics review: cost‐effectiveness of treatment alternatives for gastro‐oesophageal reflux disease

  1996cites this paper
• Severe gastroesophageal reflux disease.

  1995cites this paper
• The role of proton pump inhibitors in the treatment of gastro‐oesophageal reflux disease

  1995cites this paper
• The relationship between the control of pH and healing and symptom relief in gastro‐oesophageal reflux disease

  1995cites this paper
• An index to predict outcome of surgery for reflux esophagitis based on the AFP classification

  1995cites this paper
• Wrap session: is the Nissen slipping? Can medical treatment replace surgery for severe gastroesophageal reflux disease in children?

  1995cites this paper
• Severe gastroesophageal reflux disease. Medical and surgical options for long-term care.

  1995cites this paper
• Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study.

  1995cites this paper